Genesis Healthcare, Inc. (GEN): Price and Financial Metrics

Genesis Healthcare, Inc. (GEN): $17.90

0.21 (-1.16%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add GEN to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#12 of 69

in industry

GEN Price/Volume Stats

Current price $17.90 52-week high $23.92
Prev. close $18.11 52-week low $15.45
Day low $17.86 Volume 3,655,294
Day high $18.17 Avg. volume 4,006,531
50-day MA $19.78 Dividend yield 2.65%
200-day MA $19.25 Market Cap 11.45B

GEN Stock Price Chart Interactive Chart >

GEN POWR Grades

  • GEN scores best on the Quality dimension, with a Quality rank ahead of 86.17% of US stocks.
  • The strongest trend for GEN is in Sentiment, which has been heading down over the past 177 days.
  • GEN ranks lowest in Sentiment; there it ranks in the 31st percentile.

GEN Stock Summary

  • GEN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 86.18% of US stocks.
  • With a year-over-year growth in debt of 181.35%, GEN DIGITAL INC's debt growth rate surpasses 93.9% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for GEN comes in at -42.79% -- higher than that of just 12.03% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to GEN DIGITAL INC, a group of peers worth examining would be ENTG, ITGR, HXL, SGH, and MSCI.
  • Visit GEN's SEC page to see the company's official filings. To visit the company's web site, go to www.nortonLifeLock.com.

GEN Valuation Summary

  • GEN's EV/EBIT ratio is 16; this is 18.78% lower than that of the median Technology stock.
  • GEN's EV/EBIT ratio has moved down 5.4 over the prior 243 months.

Below are key valuation metrics over time for GEN.

Stock Date P/S P/B P/E EV/EBIT
GEN 2023-09-22 3.4 5.2 9.0 16.0
GEN 2023-09-21 3.4 5.2 9.1 16.0
GEN 2023-09-20 3.4 5.2 9.2 16.1
GEN 2023-09-19 3.4 5.2 9.1 16.0
GEN 2023-09-18 3.4 5.2 9.1 16.0
GEN 2023-09-15 3.4 5.2 9.1 16.0

GEN Growth Metrics

    The 5 year price growth rate now stands at -27.84%.
  • Its 5 year net income to common stockholders growth rate is now at 3766.98%.
  • The 3 year net cashflow from operations growth rate now stands at -34.85%.
GEN's revenue has moved up $617,000,000 over the prior 34 months.

The table below shows GEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 3,107 759 554
2022-09-30 2,873 783 591
2022-06-30 2,817 931 855
2022-03-31 2,796 974 836
2021-12-31 2,752 1,004 910
2021-09-30 2,689 967 886

GEN Price Target

For more insight on analysts targets of GEN, see our GEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $0.54 Average Broker Recommendation 2.25 (Moderate Sell)

Genesis Healthcare, Inc. (GEN) Company Bio


Genesis Healthcare provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the United States. It operates through three segments: Long-Term Care Services, Therapy Services, and Hospice and Home Health Services. The company was founded in 2003 and is based in Kennett Square, Pennsylvania.


GEN Latest News Stream


Event/Time News Detail
Loading, please wait...

GEN Latest Social Stream


Loading social stream, please wait...

View Full GEN Social Stream

Latest GEN News From Around the Web

Below are the latest news stories about GEN DIGITAL INC that investors may wish to consider to help them evaluate GEN as an investment opportunity.

Inspiring the Next Generation of Digital Citizens

NORTHAMPTON, MA / ACCESSWIRE / September 25, 2023 / GenNorton and Discovery Education launch "My Digital Life" Digital Citizenship initiativeBy Kimberly BishopDigital citizenship includes the basic skills and knowledge people need to engage safely ...

Yahoo | September 25, 2023

Gen Digital Inc. (NASDAQ:GEN) Shares Could Be 30% Below Their Intrinsic Value Estimate

Key Insights Gen Digital's estimated fair value is US$27.26 based on 2 Stage Free Cash Flow to Equity Current share...

Yahoo | September 22, 2023

Norton Launches Secure Browser for Windows PC and Mac

To help protect consumers from browser-based security, privacy and identity threats, Norton, a consumer Cyber Safety brand of Gen™ (NASDAQ: GEN), has released Norton Secure Browser.

Yahoo | September 21, 2023

Grab These 7 Winning Tech Stocks on Sale Now

Dive into these undervalued gems that stand out as promising tech stocks to buy, even within a volatile market landscape.

Josh Enomoto on InvestorPlace | September 20, 2023

Norton Consumer Cyber Safety Pulse Report: A Look at the Most Common Online Scams in 2023

Norton, a consumer Cyber Safety brand of Gen™ (NASDAQ: GEN), today released its latest Consumer Cyber Safety Pulse Report, which gives an in-depth look at the most recent scams, including those surrounding online retailers, sextortion, tech support, crypto, business emails and more.

Yahoo | September 20, 2023

Read More 'GEN' Stories Here

GEN Price Returns

1-mo -12.30%
3-mo -2.27%
6-mo 5.78%
1-year -10.52%
3-year -8.40%
5-year -6.73%
YTD -14.80%
2022 -15.81%
2021 27.59%
2020 -16.60%
2019 37.17%
2018 -31.76%

GEN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full GEN Dividend History

Continue Researching GEN

Here are a few links from around the web to help you further your research on Genesis Healthcare Inc's stock as an investment opportunity:

Genesis Healthcare Inc (GEN) Stock Price | Nasdaq
Genesis Healthcare Inc (GEN) Stock Quote, History and News - Yahoo Finance
Genesis Healthcare Inc (GEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!